Lotiglipron
A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults
Pfizer · Phase 1 · Completed · Enrollment 16
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Period 1: PF-07081532 | n/r | n/r | n/r | n/r |
| Period 2: Cyclosporine + PF-07081532 | n/r | n/r | n/r | n/r |
| Period 3: Itraconazole + PF-07081532 | n/r | n/r | n/r | n/r |
Not shown
- Period 1: PF-07081532: endpoint not reported
- Period 2: Cyclosporine + PF-07081532: endpoint not reported
- Period 3: Itraconazole + PF-07081532: endpoint not reported